azomycin has been researched along with Leishmaniasis, American in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Blanco, Z; Charris, JE; Fernandez-Moreira, E; Mijares, MR; Oviedo, HJ; RamÃrez, H; RodrÃguez, NM | 1 |
Black, C; Braillard, S; Caridha, D; Croft, SL; Ioset, JR; Leed, S; Mowbray, CE; Sciotti, RJ; Van Bocxlaer, K; Vesely, B; Wijnant, GJ; Yardley, V | 1 |
Araujo, AP; Giorgio, S | 1 |
3 other study(ies) available for azomycin and Leishmaniasis, American
Article | Year |
---|---|
In vitro evaluation and in vivo efficacy of nitroimidazole-sulfanyl ethyl derivatives against Leishmania (V.) braziliensis and Leishmania (L.) mexicana.
Topics: Animals; Antiprotozoal Agents; Leishmania braziliensis; Leishmania mexicana; Leishmaniasis, Cutaneous; Mice; Nitroimidazoles | 2021 |
Novel benzoxaborole, nitroimidazole and aminopyrazoles with activity against experimental cutaneous leishmaniasis.
Topics: Animals; Antiprotozoal Agents; Boron Compounds; Female; Inhibitory Concentration 50; Leishmaniasis, Cutaneous; Macrophages; Membrane Potential, Mitochondrial; Mice; Mice, Inbred BALB C; Nitroimidazoles; Parasite Load; Pyrazoles | 2019 |
Immunohistochemical evidence of stress and inflammatory markers in mouse models of cutaneous leishmaniosis.
Topics: Animals; Biomarkers; Cyclooxygenase 2; Cytokines; Disease Models, Animal; Immunohistochemistry; Inflammation; Leishmania; Leishmaniasis, Cutaneous; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Nitric Oxide; Nitroimidazoles; p38 Mitogen-Activated Protein Kinases; Vascular Endothelial Growth Factor A | 2015 |